Staggered Global Launch
Do you want to market/commercialise your product in some countries in Europe but not all? Specific Pharma can be your partner in new markets on an unlicensed basis.
Throughout our extensive global network, we are a trustworthy partner in providing assistance for pharmaceutical companies with a product approved in all European countries, but prioritising which markets to commercialise in. This allows pharmaceutical companies not willing to invest in international sales to focus on their main markets, while Specific Pharma provides assistance and support in the remaining countries.
When this is the case, Specific Pharma assists the company by making the product available to patients on a named patient basis/compassionate use permit. This allows physicians and patients to access commercially approved medicines that are not marketed in their own country.